Larkin Finbar 4
4 · Jazz Pharmaceuticals plc · Filed May 11, 2022
Insider Transaction Report
Form 4
Larkin Finbar
SVP, Technical Development
Transactions
- Sale
Ordinary Shares
2022-05-09$148.94/sh−1,747$260,193→ 19,462 total
Footnotes (2)
- [F1]Shares sold to satisfy tax obligations arising out of the vesting of previously granted restricted stock units.
- [F2]Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $148.92 to $149.91 The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.